Experience:
No experience
Employment Type:
Intern/Co-op
Posted:
5/8/2019
Job Category:
Engineering
Engineer-Intern
(This job is no longer available)
Axiall | Wayne, PA
loading
loading
School
Major
Grad Date
 
 

Not sure what types of jobs you are interested in?


Explore Jobs
Based on Your Education

Follow This Company
Share

Job Description

NAPCO™- invites you to further your career and participate in the cutting edge of PVC pipe and fittings products. We are looking for enthusiastic people to join our team and continue our leadership in the PVC industry.

Engineering Intern will work with the NPD team to complete a number of breakthrough innovative projects for the well and Specialty Ag businesses. These projects will be in the final product qualification, certification and pilot production phases overlapping with the time the Intern would be with the team.

NAPCO™-, a Westlake Company is an equal opportunity employer. All qualified applicants will receive consideration for employment without regard to any characteristics protected by applicable legislation.

If you are an active Westlake Chemical employee (or an employee of any Westlake Chemical affiliates), please do not apply here. Please go to your Workday homepage and click on the "Careers" worklet and view "Westlake Career Opportunities".

About Axiall

Axial Biotech, Inc. is focused on the use of genetics and the development of minimally invasive, motion preserving implants to advance the diagnosis and treatment of diseases and deformities of the human spine. Axial is the first company to pursue DNA-based pre-symptomatic and prognostic tests for common spinal conditions which will augment current clinical and surgical practices. In its initial product development initiative, Axial has made significant progress towards the discovery of a location in the human genome that is associated with adolescent idiopathic scoliosis. In addition, Axial's founders have developed five fusionless surgical devices (including the only such device currently being implanted in humans) that have the promise of expanding the current treatable scoliosis patient population by a factor of ten. Axial intends to use its proprietary genetic intellectual property in the development of bio-mechanical devices, and to apply its gene discovery/product development methodology to other spinal diseases. Spine care has historically focused on ameliorating the pain and/or fixing structural damage after it occurs. Recent technological advances in minimally invasive surgical techniques and better instrumentation have made the spine industry the hottest segment of the medical device market today, according to Start-Up magazine. Market analysis indicates a $3 billion sales potential for new instrumentation alone within 4 years, with this market compounding at greater than 20% per year. In the last 24 months, over $250 million of reported venture capital financing has flowed into spine start-ups and investors have achieved exits totaling over $1 billion, including one IPO (NuVasive). Axial's novel tests will complement the advances in surgical instrumentation by providing the spine care industry with the first to market diagnostic and prognostic tests for targeting earlier and more appropriate therapeutic interventions. Axial's surgical devices, one of which is currently in off-label use in humans, represent the only available alternative to spine fusion in the treatment of scoliosis. Axial is located in Salt Lake City, Utah, a place the New York Times recently called "an ideal genetic laboratory."